Related Articles
Combinations of elevated tissue miRNA‑17‑92 cluster expression and serum prostate‑specific antigen as potential diagnostic biomarkers for prostate cancer
MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment
miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells
Significance of the microRNA‑17‑92 gene cluster expressed in B‑cell non‑Hodgkin's lymphoma
Serum microRNAs: A new diagnostic method for colorectal cancer (Review)